← Open Payments lookup

RAMON MARTINEZ: Open Payments

NPI 1457376964 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$54,094 in 116 payments from 16 companies in 2025. Trend: 2023 $58,325 · 2024 $87,115 · 2025 $54,094

Speaker / faculty: $36,053Consulting: $7,125Travel & lodging: $4,576Food & beverage: $3,472Speaker / faculty: $2,756Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.35$28,674
Teva Pharmaceuticals USA, Inc.42$21,336
Noven Therapeutics, LLC6$2,792
Otsuka America Pharmaceutical, Inc.8$419
Vanda Pharmaceuticals Inc.3$233
Axsome Therapeutics, Inc.4$150
Otsuka Pharmaceutical Development & Commercialization, Inc.1$122
Janssen Pharmaceuticals, Inc3$71
Almatica Pharma LLC3$70
Alkermes, Inc.2$45

Products named: INGREZZA, AUSTEDO XR, Xelstrym, REXULTI, FANAPT, Auvelity, ABILIFY MAINTENA, SPRAVATO.

Industry payments across FL — which companies pay providers there.